Search Results - "Elisabetta, Ferraro"
-
1
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
Published in Oxidative medicine and cellular longevity (01-01-2018)“…Many cancer therapies produce toxic side effects whose molecular mechanisms await full elucidation. The most feared and studied side effect of chemotherapeutic…”
Get full text
Journal Article -
2
Autophagic and apoptotic response to stress signals in mammalian cells
Published in Archives of biochemistry and biophysics (15-06-2007)“…Autophagy is a highly conserved catabolic programme for degrading proteins and organelles. This process has been shown to act as a pro-survival or pro-death…”
Get full text
Journal Article -
3
COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
Published in Journal of neurology (01-09-2021)Get full text
Journal Article -
4
Polymeric Systems for the Controlled Release of Flavonoids
Published in Pharmaceutics (01-02-2023)“…Flavonoids are natural compounds that are attracting great interest in the biomedical field thanks to the wide spectrum of their biological properties. Their…”
Get full text
Journal Article -
5
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
Published in Neurotherapeutics (01-01-2022)“…The potential impact of disease-modifying therapies (DMTs) for multiple sclerosis (MS) on COVID-19 vaccination is poorly understood. According to recent…”
Get full text
Journal Article -
6
Response to “Frailty in multiple sclerosis: A closer look at the deficit accumulation framework”
Published in Multiple sclerosis (01-05-2022)Get full text
Journal Article -
7
Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs
Published in International journal of molecular sciences (20-08-2021)“…Cancer cachexia displays a complex nature in which systemic inflammation, impaired energy metabolism, loss of muscle and adipose tissues result in…”
Get full text
Journal Article -
8
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis
Published in Journal of neurology (01-06-2021)“…Background Dimethyl fumarate (DMF) is an oral drug approved for Relapsing Multiple Sclerosis (RMS) patients. Grade III lymphopenia is reported in 5–10%…”
Get full text
Journal Article -
9
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for Ranolazine
Published in Scientific reports (17-11-2023)“…Microglia chronic activation is a hallmark of several neurodegenerative diseases, including the retinal ones, possibly contributing to their etiopathogenesis…”
Get full text
Journal Article -
10
Operationalization of a frailty index in patients with multiple sclerosis: A cross-sectional investigation
Published in Multiple sclerosis (01-10-2021)“…Background: Frailty is an age-related status of increased vulnerability to stressors caused by the accumulation of multiple health deficits. This construct may…”
Get full text
Journal Article -
11
Molecular control of neuromuscular junction development
Published in Journal of cachexia, sarcopenia and muscle (01-03-2012)“…Skeletal muscle innervation is a multi-step process leading to the neuromuscular junction (NMJ) apparatus formation. The transmission of the signal from nerve…”
Get full text
Journal Article -
12
Advance in the Diagnostics and Management of Musculoskeletal Diseases
Published in Diagnostics (Basel) (29-06-2022)“…Musculoskeletal disorders are a broad spectrum of diseases, affecting muscles, bones, ligaments, and tendons worldwide [...]…”
Get full text
Journal Article -
13
The mitochondrial metabolic reprogramming agent trimetazidine as an ‘exercise mimetic’ in cachectic C26‐bearing mice
Published in Journal of cachexia, sarcopenia and muscle (01-12-2017)“…Background Cancer cachexia is characterized by muscle depletion and exercise intolerance caused by an imbalance between protein synthesis and degradation and…”
Get full text
Journal Article -
14
Disease-Modifying Drugs and Breastfeeding in Multiple Sclerosis: A Narrative Literature Review
Published in Frontiers in neurology (15-04-2022)“…Pregnancy-related issues in women with multiple sclerosis (MS) have been receiving increasing attention, with particular interest for the use of…”
Get full text
Journal Article -
15
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy
Published in Multiple sclerosis (01-10-2024)“…Background: Evidence on the impact of dimethyl fumarate (DMF) during pregnancy in women with multiple sclerosis (MS) is limited. Objectives: To investigate…”
Get full text
Journal Article -
16
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
Published in Multiple sclerosis (01-12-2022)“…Background: Definitions for reliable identification of transition from relapsing-remitting multiple sclerosis (MS) to secondary progressive (SP)MS in clinical…”
Get full text
Journal Article -
17
Pilocytic Astrocytoma-Derived Cells in Peripheral Blood: A Case Report
Published in Frontiers in oncology (27-10-2021)“…Imaging limitations, invasive tissue biopsies and poor information over the course of treatment to evaluate ‘real-time’ tumor dynamics justify the emerging use…”
Get full text
Journal Article -
18
Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists
Published in Frontiers in neurology (15-07-2022)“…BackgroundIn multiple sclerosis (MS), bridging therapies are usually administered when switching from one therapy to another. Such treatments generally consist…”
Get full text
Journal Article -
19
Metabolic Reprogramming Promotes Myogenesis During Aging
Published in Frontiers in physiology (10-07-2019)“…Sarcopenia is the age-related progressive loss of skeletal muscle mass and strength finally leading to poor physical performance. Impaired myogenesis…”
Get full text
Journal Article -
20
CXCL12 prolongs naive CD4 + T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation
Published in International journal of cardiology (01-12-2016)“…Abstract Background Naive T lymphocytes recirculate through the body, traveling from secondary lymphoid organs through tissues and via lymphatic vessels and…”
Get full text
Journal Article